Procurement of Remaining Items of Drugs & Medicines for Sindh Institute of Cardiovascular Diseases Karachi

The Sindh Institute of Cardiovascular Diseases (SICVD), Karachi, invites bids for the procurement of remaining items of drugs and medicines required for its network hospitals across Sindh including Sukkur, Larkana, Nawabshah, TMK, Hyderabad, Sehwan, Mithi, Khairpur, Liyari, and Baldia. This procurement is conducted under the Single Stage Two Envelope procedure as per Sindh Public Procurement Rules, 2010 (as amended). Items being procured include a comprehensive list of pharmaceutical products such as ACEFYLLINE (PIPERAZINE) 120ML SYRUP, ACETAZOLAMIDE 250MG TAB, ADENOSINE 30MG/10ML INJ, ADRENALINE 1ML INJ, AMIKACIN 1000MG/2ML INJ, ATORVASTATIN 10MG TAB, CALCIUM CHLORIDE 20% INJ, DEXLANSOPRAZOLE 30MG CAP, INSULIN-N 10ML INJ, MEROPENEM 250MG INJ, PANTOPRAZOLE SODIUM 40MG TAB, and many others totaling over 140 distinct pharmaceutical items with specified quantities and bid security values. The technical scope requires that all supplied drugs and medicines conform to the standards of the Drugs Act 1976 and relevant regulations. Suppliers must provide detailed technical specifications, registration numbers, country of origin, and valid licenses. The supply must be delivered in commercial packs and maintain cold chain facilities where applicable. The contract period is one year, extendable subject to performance and approval. Delivery locations include multiple SICVD network hospitals across Sindh. Eligibility criteria include valid manufacturing or import licenses, GMP certificates, FBR active taxpayer status, minimum average annual turnover of PKR 25 million, and submission of bid security as per item requirements. Bidders must be manufacturers or authorized distributors with original authorization letters. The bid submission and opening will be conducted electronically via the EPADS portal, with original bid security submitted physically to SICVD's head office in Karachi. The deadline for bid submission is 16th September 2026 at 11:00 AM, with bid opening at 11:30 AM the same day. Bidders are advised to carefully review all mandatory documents and ensure compliance with technical and financial evaluation criteria. Earnest money and performance security requirements are strictly enforced. One practical tip for bidders is to ensure timely submission of samples before the bid opening date, as late samples will not be accepted and may lead to disqualification. This procurement offers a significant opportunity for pharmaceutical suppliers to engage with a major public health institution in Sindh, with clear guidelines and a transparent evaluation process ensuring fair competition and quality assurance.